Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05182931
Title A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Olivia Newton-John Cancer Research Institute
Indications

thyroid gland cancer

Therapies

Dabrafenib + Trametinib

Trametinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST